![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|13|6|753-763
ISSN: 1389-4501
Source: Current Drug Targets, Vol.13, Iss.6, 2012-05, pp. : 753-763
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
GV 1001 shows potential in patients with non-resectable, untreated pancreatic cancer
Inpharma, Vol. 1, Iss. 1572, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Endoscopic screening worth it for pancreatic cancer in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 402, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Optimising Treatment for Resectable Rectal Cancer: Is Preoperative Therapy Beneficial?
By Ngan S.Y.K.
Drugs & Aging, Vol. 18, Iss. 2, 2001-02 ,pp. :